Authors


Jürgen Schäfer

Latest:

European Pediatric Informed Consent and AF: Current Status of Country Requirements

The Pediatric Working Group of EUCROF launched an initiative to achieve standardization of generic Informed Consent Form and Assent Form templates within European countries. The differences are noted based on a prior survey.


Michael Weis

Latest:

The Quality Coach

The right person can successfully promote proper management of quality and compliance, leading to desired clinical trial outcomes.


Murtuza Bharmal

Latest:

Direct-to-Patient Enrollment Strategies

A comparison of the yields and costs of online outreach methods to other recruitment techniques.


Pietro Bonacossa

Latest:

New Ways to Recruit Trial Subjects

To minimize time to market, sponsors must explore new subject recruitment techniques.



David Levin

Latest:

Medical Device Trials

Understanding the United States' regulatory pathways and clinical operations.


Jim Kremidas

Latest:

Perspective and Hope From the ‘Other Side’

Jim Kremidas, former executive director, Association of Clinical Research Professionals, shares his experiences as a patient in clinical trials.


James R Langabeer II

Latest:

Financial Simulation Modeling

With a PC and some software you can generate realistic projections that save time and money.


Aymara Lorente, MD

Latest:

Documenting Adverse Events

Analysis of hematology and blood chemistry's AEs in sponsor's databases.


Michael E. Marcarelli

Latest:

Medical Device Compliance

A probability sampling assessment by FDA takes a look at compliance in the medical device world.


Jessica Dolfi

Latest:

Mastering Currency Fluctuation

Step-by-step process for budgeting global trials that uses a Currency Risk Management method.


Christopher Dell

Latest:

Planning an EDC Clinical Trial

Readers share their experiences


Mike Page

Latest:

Early Labeling Pays

Even before trials start, compiling a "target label" can add value by helping steer product development.


Ulrike Shwarz-Boeger

Latest:

EHR and EDC Integration in Reality

An evaluation of the Munich Pilot and the affects of the EHR-EDC integration solution.


David Handelsman

Latest:

A Canary in a Coal Mine?

How the ability to apply text mining and signal detection algorithms to social media's real-time data provides unheard of value.


Danielle Egnozzi

Latest:

Growth for Welsh Companies

A rising initiative in Wales led by the International Business of Wales (IBW) promotes company growth in the region.


Liana Martinez Pérez

Latest:

Documenting Adverse Events

Analysis of hematology and blood chemistry's AEs in sponsor's databases.


Michelle Middle

Latest:

Innovative Early Phase Trial Design

Incorporating original study design accelerates better development decisions.


Barbara Tardiff

Latest:

An Assessment of Adaptive

Understanding and using adaptive trial design to achieve the most of its available advantages.


Barbara Wilkinson Brito

Latest:

Documenting Adverse Events

Analysis of hematology and blood chemistry's AEs in sponsor's databases.


Darlene Panzitta

Latest:

Mandatory Certification—It’s Time

It is time for mandatory certification to be required for everyone involved in a clinical study.


Nitin Patel

Latest:

Simulation: A Critical Tool in Adaptive

How simulation can help in the planning and implementation of adaptive clinical trials.


Nadia Harbeck

Latest:

EHR and EDC Integration in Reality

An evaluation of the Munich Pilot and the affects of the EHR-EDC integration solution.


Martha Fors, MD

Latest:

Documenting Adverse Events

Analysis of hematology and blood chemistry's AEs in sponsor's databases.


Kayda Norman

Latest:

Survey Reveals Patient Recruitment is the Biggest Challenge in Pediatric Trials

A new study by Premier Research shows that both American and European pharmaceutical companies are facing similar problems in regards to pediatric trial regulations.


George Kuzmanovski

Latest:

Mastering Currency Fluctuation

Step-by-step process for budgeting global trials that uses a Currency Risk Management method.


Jeffrey P. Trotter

Latest:

Reviewing FDA’s Latest Guidance on RWD

Roadmap of twists and turns that lie ahead following most recent draft issued in September.


Molly Blake-Michaels

Latest:

Operation Adaptive

A concise look at this nontraditional approach to clinical studies that explains the how and why of it.


Jeffrey Helton

Latest:

Financial Simulation Modeling

With a PC and some software you can generate realistic projections that save time and money.


Jonathan S. Helfgott, MS

Latest:

Analysis: FDA’s COVID-19 Accelerated Pathways

Lessons learned from FDA’s current process and proposed alternative review strategies.

© 2024 MJH Life Sciences

All rights reserved.